Jeff Yass’s Centessa Pharmaceuticals CNTA Stock Holding History

Jeff Yass’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-173,400	Closed	-$6.89M	–	13515
2026 Q1	$6.89M	Buy	173,400 +76,700	+79%	+$1.96M	﹤0.01%	3699
2025 Q4	$2.42M	Buy	96,700 +19,000	+24%	+$481K	﹤0.01%	5246
2025 Q3	$1.88M	Buy	77,700 +8,700	+13%	+$155K	﹤0.01%	5926
2025 Q2	$907K	Buy	69,000 +12,300	+22%	+$156K	﹤0.01%	7684
2025 Q1	$815K	Buy	+56,700	New	+$928K	﹤0.01%	7776
2024 Q4	–	Sell	-23,500	Closed	-$376K	–	12312
2024 Q3	$376K	Buy	+23,500	New	+$288K	﹤0.01%	9119

Jeff Yass's CNTA Position: Q2 2026 in Review

Jeff Yass sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 17,737 shares — an estimated $705K sold.

Jeff Yass first reported a position in CNTA in Q1 2023 and held it in 6 quarters. The position peaked at $12.9M in Q1 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Jeff Yass reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Jeff Yass sold 17,737 Centessa Pharmaceuticals shares in Q2 2026, an estimated $705K.
Jeff Yass first reported a position in Centessa Pharmaceuticals in Q1 2023 and held it in 6 quarters.
Jeff Yass's Centessa Pharmaceuticals position peaked at $12.9M in Q1 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.